HOLX posts Q4 GYN Surgical revenues of $172.5M, up 10.2% year over year. Hologic's growth was driven by MyoSure, Fluent and contributions from the Gynesonics acquisition. Hologic's International sales ...
MyoSure and Fluent have powered HOLX's Surgical growth at a 7.6% CAGR over the last decade. HOLX sees solid uptake for Fluent Pro and growing demand abroad, boosting Surgical momentum. Acquisitions ...
Hologic, Inc. HOLX recently signed a definitive agreement to acquire Bolder Surgical for a deal value of nearly $160 million, subject to working capital and other customary closing adjustments. The ...
The growing prevalence of gynecological diseases and increasing government investments to improve women’s health are fueling the demand for gynecology surgical instruments. According to Zion Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results